Find research datasets worth reusing

Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage

ClinicalTrials.gov study NCT04820972. IPD Sharing: Not stated. Countries: 1. Publications: 3.

Brain Hemorrhage and Functional Outcome in Stroke Patients With CAA Features on Pre-thrombolysis MRI Treated With Intravenous Thrombolysis (Thrombolysis in CAA) ( Thromb in CAA )

ClinicalTrials.gov study NCT05565144. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM)

ClinicalTrials.gov study NCT06908785. IPD Sharing: NO. Countries: 1. Publications: 23.

Online Spanish Cognitive Intervention Program for Spanish-Speaking Latino/Hispanic Subarachnoid Hemorrhage Patients

ClinicalTrials.gov study NCT03621397. IPD Sharing: NO. Countries: 1. Publications: 15.

Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

ClinicalTrials.gov study NCT00056238. IPD Sharing: Not stated. Countries: 1. Publications: 1.

The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT02129010. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Early Norepinephrine in Trauma Patients With Hemorrhagic Shock

ClinicalTrials.gov study NCT06977659. IPD Sharing: NO. Countries: 1. Publications: 3.

Observational Study of Patients With Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT02890004. IPD Sharing: NO. Countries: 1. Publications: 1.

Osmotic Therapy for Patients With Severe Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT05858060. IPD Sharing: Not stated. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →

HMGB1 Release From Hemorrhagic Shock Patients

ClinicalTrials.gov study NCT03535441. IPD Sharing: YES. Countries: 1. Publications: 4.

dryad28/100

Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature

Objective To assess the risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease (AD) compared to non-AD subjects with similar risk profiles. Methods A search was conducted on Embase and Medline for reports published up to September 26, 2018. Studies were included if they: 1) assessed incidence of stroke in patients diagnosed with AD; 2) included patients with no history of stroke; and 3) reported outcomes by stroke subtype. The main outcome was relative risk of ischemic or hemorrhagic stroke. Further, the rate of stroke occurrence per 1000 person-years was assessed. A random effects meta-analysis was undertaken. The risk of bias in included studies was assessed in terms of selection, comparability and outcome. Results 3,605 studies were screened in the title and abstract phase after removing duplicates, and 88 eligible studies were screened for full text. Eight studies met the inclusion criteria representing 121,719 subjects (AD=73,044; non-AD=48,675). Five studies were included in the relative risk analysis, among which four studies applied formal matching criteria of 44,544 AD and 44,660 non-AD subjects. The included studies were based on nation-wide registries from Finland, Sweden, Taiwan (2), UK (2), one clinic-based study from the Netherlands and one US population-based cohort. Among AD patients, the incidence rate of hemorrhagic stroke was 3.41/1000-person years (95% CI 2.70, 4.32) and 2.23 (95% CI 1.72, 2.88) among AD-cases and non-AD controls respectively. This is in contrast to 13.98 (95% CI 9.86, 19.81) and 12.12 (95% CI 7.55, 19.46) for ischemic stroke among AD-cases and non-AD controls respectively. Compared to non-AD subjects with similar risk profiles, AD patients had a relative risk of 1.42 (95% CI 1.23, 1.64) for hemorrhagic stroke and 1.15 (95% CI 0.89, 1.48) for ischemic stroke. Conclusion Compared to non-AD subjects with similar risk profiles, AD patients are likely at higher risk of hemorrhagic, but not ischemic stroke.

opencc-zeroAug 2021View details →

controlledIPD-YESFeb 2026View details →

Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)

ClinicalTrials.gov study NCT06559072. IPD Sharing: YES. Countries: 1. Publications: 0.

INVEST Feasibility - Minimally Invasive Endoscopic Surgery With Apollo in Patients With Brain Hemorrhage

ClinicalTrials.gov study NCT02654015. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Topical Bevacizumab for the Management of Recurrent Epistaxis in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

ClinicalTrials.gov study NCT01397695. IPD Sharing: Not stated. Countries: 1. Publications: 0.

Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)

ClinicalTrials.gov study NCT00666328. IPD Sharing: Not stated. Countries: 2. Publications: 0.

controlledIPD-YESFeb 2026View details →

Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients After Intracerebral Hemorrhage

ClinicalTrials.gov study NCT02830152. IPD Sharing: YES. Countries: 4. Publications: 0.

Trial of Cooling for Patients With Excel Cryo Cooling System in Intracerebral Hemorrhage (ICH)

ClinicalTrials.gov study NCT01933230. IPD Sharing: NO. Countries: 1. Publications: 0.

Sphenopalatine Block in Headache in Patients With Non-traumatic Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT06735261. IPD Sharing: NO. Countries: 0. Publications: 8.

A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage

ClinicalTrials.gov study NCT03038087. IPD Sharing: NO. Countries: 1. Publications: 0.

Safety and Efficacy Study of Clevidipine to Control Hypertension in Patients Admitted With Aneurysmal Subarachnoid Hemorrhage

ClinicalTrials.gov study NCT00978822. IPD Sharing: Not stated. Countries: 1. Publications: 0.